
Apriglim 1 Tablet
Marketer
Aprica Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (1mg)
Overview Apriglim 1 Tablet
Glimepiride, a single-dose tablet, is a sulfonylurea drug indicated for managing type 2 diabetes in adults. It effectively regulates blood glucose, mitigating the risk of severe diabetic complications, including vision impairment and renal dysfunction. Glimepiride may be administered independently or in conjunction with other therapies. Optimal efficacy is achieved by consistent daily use, ideally just before or with the first meal. Dosage is determined individually by your physician and may be adjusted based on glucose monitoring. Discontinuation should only occur under medical supervision as abrupt cessation can lead to elevated blood sugar and subsequent complications such as neuropathy, retinopathy, nephropathy, and peripheral vascular disease. Successful diabetes management necessitates adherence to a comprehensive plan incorporating dietary modifications, regular physical activity, and weight management as directed by your healthcare provider. Commonly reported adverse effects include hypoglycemia (low blood sugar), accompanied by symptoms like tremors, sweating, and lightheadedness; nausea; cephalgia; asthenia; and vertigo. Prompt glucose replenishment using readily available sugars is crucial in managing hypoglycemic episodes. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Weight gain is a possible side effect. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or significant hepatic or renal impairment. Prior medical history, including cardiovascular disease, thyroid disorders, or endocrine imbalances, should be disclosed to your physician before initiating treatment. Pregnant or lactating women require specific medical consultation. Regular blood glucose monitoring, along with periodic blood tests assessing complete blood count and liver function, is recommended.
Uses of Apriglim 1 Tablet
Managing type 2 diabetes
Major Benefits of Apriglim 1 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Apriglim (1 tablet) with a meal.
Common Side effects of Apriglim 1 Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Dizziness
- Weakness
How to use Apriglim 1 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not crush, chew, or divide it. Consume Apriglim (1 tablet) with a meal.
How Apriglim 1 Tablet works:
One Apriglim tablet is an anti-hyperglycemic agent. Its mechanism of action involves stimulating pancreatic insulin secretion to reduce blood sugar levels.
SAFETY ADVICE
AlcoholUNSAFE
Combining Apriglim 1 Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Apriglim 1 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Using Apriglim 1 Tablet while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a risk to the infant. Close monitoring of the nursing infant's blood sugar levels is recommended when the mother takes Apriglim 1 Tablet.
DrivingCAUTION
Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Apriglim 1 Tablet cautiously, potentially requiring dosage modification. Consult a physician before use. Apriglim 1 Tablet is contraindicated in individuals with severe kidney disease due to the risk of severe hypoglycemia, which may resolve over an extended period.
LiverCAUTION
Caution is advised when prescribing Apriglim 1 Tablet to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is recommended. Apriglim 1 Tablet is contraindicated in patients exhibiting severe liver disease due to the risk of profound hypoglycemia, although this may resolve over an extended period.
What if you forget to take Apriglim 1 Tablet :
Omit the forgotten Apriglim 1 Tablet dose; resume your regular dosing schedule.
Facts to Know About Apriglim 1 Tablet
| Label | Value |
|---|---|
| Chemical Category | Advanced Sulfonylurea |
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
